Caisse de depot et placement du Quebec

Position in RPRX — Royalty Pharma plc

CIK 898286 Montreal, A8

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$56,291,644

+$45,832,697 QoQ

Shares Held

1,003,953

+360.5% QoQ

Ownership

0.175%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#59

of 646 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Caisse de depot et placement du Quebec holds $670,874,502 across 12 Biotechnology names. RPRX ranks #6 (8.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	250,608	$156,264,112
2	INCY	Incyte Corp	1,370,503	$155,360,220
3	EXEL	Exelixis, Inc.	2,094,299	$113,950,808
4	HALO	Halozyme Therapeutics, Inc.	1,072,439	$83,939,800
5	BMRN	Biomarin Pharmaceutical Inc	1,236,446	$70,749,440
6	RPRX	Royalty Pharma plc This page	1,003,953	$56,291,644
7	ALNY	Alnylam Pharmaceuticals, Inc.	85,748	$25,812,720
8	VRTX	Vertex Pharmaceuticals Inc / Ma	13,042	$6,478,352

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$56,291,644	1,003,953	+360.5%	Shares	Sole	2026-08-14
2026-03-31	$10,458,947	218,031	-76.1%	Shares	Sole	2026-05-14
2025-12-31	$35,227,508	911,685	+240.6%	Shares	Sole	2026-02-17
2025-09-30	$9,444,456	267,700	+241.8%	Shares	Sole	2025-11-14
2025-06-30	$2,822,121	78,327	-89.3%	Shares	Sole	2025-08-14
2025-03-31	$22,768,513	731,401	+2.6%	Shares	Sole	2025-05-14
2024-12-31	$18,183,145	712,785	+671.0%	Shares	Sole	2025-02-14
2024-03-31	$2,807,767	92,452	+29.5%	Shares	Sole	2024-05-14
2023-03-31	$2,572,542	71,400	+276.0%	Shares	Sole	2023-05-12
2021-03-31	$828,300	18,989	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.